Follow this preprint

Immunogenicity and Safety of Gamma, Omicron BA.4/5 and Bivalent SARS-CoV-2 RBD-based Protein Booster Vaccines in Adults Previously Immunized with Different Vaccine Platforms: a Phase II/III, Randomized, Clinical Trial

Gonzalo Perez-Marc, Lorena M. Coria, Ana Ceballos, Juan Manuel Rodriguez, Mónica E. Lombardo, Laura Bruno, Federico Páez Córdoba, Clara G. Fascetto Cassero, Melina Salvatori, Mayra Rios Medrano, Fabiana Fulgenzi, María F. Alzogaray, Analía Mykietiuk, Ignacio Leandro Uriarte, Nicolás Itcovici, Tomás Smith Casabella, Gonzalo Corral, Miriam Bruno, Oscar Roldán, Sebastián A. Nuñez, Florencia Cahn, Gustavo A. Yerino, Alejandra Bianchi, Virginia Micaela Braem, Analía Christmann, Santiago Corradetti, Martín Claudio Darraidou, Lucila Di Nunzio, Tatiana Belén Estrada, Rocío López Castelo, Carla Graciela Marchionatti, Lucila Pitocco, Virgina Macarena Trias Uriarte, Cristian Jorge Wood, Romina Zadoff, Florencia Bues, Rosa M. Garrido, Laboratorio Pablo Cassará group for ARVAC, Agostina Demaría, Lineia Prado, Celeste Pueblas Castro, Lucas Saposnik, Jorge Geffner, Federico Montes de Oca, Julio C. Vega, Juan Fló, Pablo Bonvehí, Jorge Cassará, Karina A. Pasquevich, Juliana Cassataro
doi: https://doi.org/10.1101/2024.05.06.24306575
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Data Availability

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

Back to top
Posted May 06, 2024.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Immunogenicity and Safety of Gamma, Omicron BA.4/5 and Bivalent SARS-CoV-2 RBD-based Protein Booster Vaccines in Adults Previously Immunized with Different Vaccine Platforms: a Phase II/III, Randomized, Clinical Trial
Gonzalo Perez-Marc, Lorena M. Coria, Ana Ceballos, Juan Manuel Rodriguez, Mónica E. Lombardo, Laura Bruno, Federico Páez Córdoba, Clara G. Fascetto Cassero, Melina Salvatori, Mayra Rios Medrano, Fabiana Fulgenzi, María F. Alzogaray, Analía Mykietiuk, Ignacio Leandro Uriarte, Nicolás Itcovici, Tomás Smith Casabella, Gonzalo Corral, Miriam Bruno, Oscar Roldán, Sebastián A. Nuñez, Florencia Cahn, Gustavo A. Yerino, Alejandra Bianchi, Virginia Micaela Braem, Analía Christmann, Santiago Corradetti, Martín Claudio Darraidou, Lucila Di Nunzio, Tatiana Belén Estrada, Rocío López Castelo, Carla Graciela Marchionatti, Lucila Pitocco, Virgina Macarena Trias Uriarte, Cristian Jorge Wood, Romina Zadoff, Florencia Bues, Rosa M. Garrido, Laboratorio Pablo Cassará group for ARVAC, Agostina Demaría, Lineia Prado, Celeste Pueblas Castro, Lucas Saposnik, Jorge Geffner, Federico Montes de Oca, Julio C. Vega, Juan Fló, Pablo Bonvehí, Jorge Cassará, Karina A. Pasquevich, Juliana Cassataro
medRxiv 2024.05.06.24306575; doi: https://doi.org/10.1101/2024.05.06.24306575
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

1

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.